ALS treatment PrimeC slows disease progression by 36% phase 2b trial results show
NeuroSense Therapeutics has announced positive phase 2b results for a drug combination designed to treat amyotrophic lateral sclerosis (ALS).
Archives for July 2, 2024
Esteve invests €100 million in Spanish API manufacturing muscle
The Spanish company Esteve Pharmaceuticals is building a manufacturing unit in its Girona plant with the aim to expand its production of active pharmaceutical ingredients (APIs).
Advancing sleep health: Wearable technologies revolutionize clinical trials and patient care
Christine Guo, chief scientific officer at ActiGraph, discusses the pivotal role of wearable health technologies in revolutionizing sleep health measurement within clinical trials.